Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2000
11/30/2000WO2000071679A2 Human oxidoreductase proteins
11/30/2000WO2000071585A1 Human antibodies to staphylococcus aureus
11/30/2000WO2000071584A1 Seven transmembrane receptor genes
11/30/2000WO2000071581A1 Novel polypeptide
11/30/2000WO2000071574A2 Antigenic neisserial peptides
11/30/2000WO2000071573A2 Immunogenic peptides derived from mage and the use thereof
11/30/2000WO2000071566A2 Novel organic anion transport proteins
11/30/2000WO2000071564A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/30/2000WO2000071160A1 MEDICINAL COMPOSITIONS CONTAINING ANTI-Fas ANTIBODY
11/30/2000WO2000071159A1 Use of antibodies identifying the interleukin-2 receptor for preventing and/or treating hiv infections
11/30/2000WO2000071152A1 Fibroblast growth factor 10
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071142A1 Method for preparing dual virally inactivated immune globulin for intravenous administration
11/30/2000WO2000050607A3 Goodpasture antigen binding protein
11/30/2000WO2000047750A3 Metalloproteases of the neprilysin family
11/30/2000WO2000044900A3 Nucleic-acid binding proteins
11/30/2000WO2000044768A3 Methods of isolating the androgenic sex hormone from crustacean prawn and marine shrimp and methods of use
11/30/2000WO2000044404A3 Methods for inhibiting brain tumor growth by using selected integrin antagonists
11/30/2000WO2000043790A3 Compositions and methods for the diagnosis and treatment of tumor
11/30/2000WO2000043525A3 Metalloproteinase-disintegrin family members: svph dnas and polypeptides
11/30/2000WO2000042201A3 Human peptidases
11/30/2000WO2000042188A3 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
11/30/2000WO2000042172A3 Human homologues of proteins regulated by circadian rhythms
11/30/2000WO2000042072A3 Polypeptide variants with altered effector function
11/30/2000WO2000034481A3 DRUG TARGETS IN $i(CANDIDA ALBICANS)
11/30/2000WO2000033082A3 Methods for quantitation of hla-dr and cd11b
11/30/2000WO2000028027A3 Corticosteroid synthesis-associated genes
11/30/2000WO2000018918A3 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/30/2000WO2000014119A3 Bifunctional antibodies and their use in targeting anti-tumour agents
11/30/2000DE19924199A1 Tumorassoziiertes Antigen Tumor-associated antigen
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374550A1 Antigenic neisserial peptides
11/30/2000CA2374520A1 Secreted alpha-helical protein - 32
11/30/2000CA2374476A1 Interaction-activated proteins
11/30/2000CA2374432A1 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000CA2374413A1 Human oxidoreductase proteins
11/30/2000CA2374354A1 Immunogenic peptides derived from mage and the use thereof
11/30/2000CA2374341A1 Novel polypeptide
11/30/2000CA2373992A1 Medicinal compositions containing anti-fas antibody
11/30/2000CA2373991A1 Use of antibodies identifying the interleukin-2 receptor for preventing and/or treating hiv infections
11/30/2000CA2373693A1 Seven transmembrane receptor genes
11/30/2000CA2373221A1 Human antibodies to staphylococcus aureus
11/30/2000CA2371828A1 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/30/2000CA2371500A1 Expression products of genes involved in diseases related to cholesterol metabolism
11/30/2000CA2371356A1 Method for preparing dual virally inactivated immune globulin for intravenous administration
11/30/2000CA2370332A1 Ers-genes, method of screening for chemical compounds capable of inducing ers in plants
11/29/2000EP1055126A1 Methods and compositions for diagnosis of hepatoma
11/29/2000EP1054995A1 GABAB-R2a, A 7TM RECEPTOR
11/29/2000EP1054984A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
11/29/2000EP1054982A2 Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides
11/29/2000EP1054981A2 Prostate-associated serine protease
11/29/2000EP1054980A1 HUMAN HEPARANASE POLYPEPTIDE AND cDNA
11/29/2000EP1054975A1 Splice variants of p101 protein
11/29/2000EP1054971A2 Group b streptococcus antigens
11/29/2000EP1054969A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
11/29/2000EP1054968A1 Apoptosis inducing molecule ii and methods of use
11/29/2000EP1054967A1 Connective tissue growth factor homologs
11/29/2000EP1054963A1 Sequences of an ih ionic channel and the use thereof
11/29/2000EP1054962A2 Caf1-related protein
11/29/2000EP1054961A2 Human short-chain tnf-receptor family protein
11/29/2000EP1054958A1 Human serine protease and serpin polypeptides
11/29/2000EP1054953A1 NOVEL pgsA
11/29/2000EP1054905A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054903A1 Fishboy, a g-protein coupled receptor
11/29/2000EP1054896A1 ANALGESIC PEPTIDES FROM VENOM OF $i(GRAMMOSTOLA SPATULATA) AND USE THEREOF
11/29/2000EP1054894A1 Breast cancer resistance protein (bcrp) and the dna which encodes it
11/29/2000EP1054693A1 Inhibitors of complement activation
11/29/2000EP1054692A2 Antibodies against human cd40
11/29/2000EP1054691A1 Skin care compositions
11/29/2000EP1054689A1 Strategically modified hepatitis b core proteins and their derivatives
11/29/2000EP1054688A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
11/29/2000EP1054687A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
11/29/2000EP0991770B1 Prostate cancer gene
11/29/2000EP0749323B1 Methods for modulating t cell anergy
11/29/2000EP0632810B1 New biotinylation reagent
11/29/2000EP0555205B1 Dna encoding a growth factor specific for epithelial cells
11/29/2000CN1275164A Neisseria lactoferrin binding protein
11/29/2000CN1275162A Death domain containing receptor 5
11/29/2000CN1275161A Monoclonal antibody 3-6-A specific to surface of dendritic cells among the peripheral blood leukocytes
11/29/2000CN1275085A Cytolysis of target cell, reagent and composition for cytolysis and compound for preparing these reagents
11/29/2000CN1275050A Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity
11/29/2000CN1274726A Human tobule related protein 1A/1B light chain 3 and its code sequence, preparation and application
11/28/2000US6153814 Polypeptide compositions toxic to lepidopteran insects and methods for making same
11/28/2000US6153739 Polynucleotides encoding human uridine diphosphate galactose-4-epimerase
11/28/2000US6153732 Kit for detecting analyte indicative of type II collagen resorption in vivo
11/28/2000US6153728 A protein encoded by an isolated nucleic acid molecule, the complementaray sequence of which hybridizes; producing a specific polyclonal antibodies
11/28/2000US6153583 OP-3 induced morphogenesis
11/28/2000US6153430 Used as indicator of the presence of ovarian cancer tumor cells
11/28/2000US6153417 CSAPK-1 protein and uses therefor
11/28/2000US6153406 Transforming escherichia coli cells with vector coding for protein and selectable marker, culturing in media containing glucose and selection agent, protein is expressed and found in inclusion bodies
11/28/2000US6153395 ICAM-related protein
11/28/2000US6153392 Devices and methods comprising an HBcAg from hepatitis B virus
11/28/2000US6153378 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
11/28/2000US6153200 Administering an isolated and purified bacterial dnajp1 peptide having the amino acid sequence
11/28/2000US6153194 Borrelia burgdorferi outer membrane proteins
11/28/2000US6153192 An amino acid sequence consisting of at least 6 contiguous amino acids and no more than 39 contiguous amino acids found at positions 144-183 of human microglobulin; for use in immunoassay to determine human microglobulin in a sample
11/28/2000US6153191 Giardia treatment and antibody
11/28/2000US6153190 Monoclonal antibodies which are receptor agonists; use as the immunizing antigen
11/28/2000US6153189 Human TRK receptors and neurotrophic factor inhibitors
1 ... 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 ... 1494